Orphazyme Overlap Studies Triple Exponential Moving Average

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>OR</div>
ORPHA -- Denmark Stock  

DKK 104.60  0.80  0.76%

Orphazyme overlap-studies tool provides you with the Overlap Studies execution environment for running Triple Exponential Moving Average study against Orphazyme. Orphazyme overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.
Symbol
Refresh

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Orphazyme AS Triple Exponential Moving Average indicator shows smoothing effect of Orphazyme price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average. View also all equity analysis or get more info about triple exponential moving average overlap studies indicator.

Additional Technical Research

About Orphazyme Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orphazyme AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orphazyme AS based on widely used predictive technical indicators. In general, we focus on analyzing Orphazyme stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orphazyme's daily price indicators and compare them against related drivers such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Orphazyme's intrinsic value. In addition to deriving basic predictive indicators for Orphazyme, we also check how macroeconomic factors affect Orphazyme price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Bollinger
Band Projection (param)
LowerMiddle BandUpper
90.7098.89107.08
Details
Hype
Prediction
LowEstimated ValueHigh
100.39104.60108.81
Details
Intrinsic
Valuation
LowReal ValueHigh
81.8186.02115.06
Details
Naive
Forecast
LowNext ValueHigh
110.79115.00119.21
Details
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was founded in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.

Current Sentiment - ORPHA

Orphazyme AS Investor Sentiment

Macroaxis portfolio users are evenly split in their perspective on investing in Orphazyme AS. What is your perspective on investing in Orphazyme AS? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Investors are also interested in

Purchased few shares
Active few hours ago
Purchased few shares
Active few hours ago
Purchased over 100 shares
Active few hours ago
Please check Your Equity Center. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page